21 May 2013
Keywords: cilengitide, promotes, cancer, growth, research, uk-funded, scientists
Article | 30 March 2009
Cancer Research UK-funded scientists have found evidence to suggest that low doses of Merck KGaA's cilengitide in laboratory studies can ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
30 March 2009
20 May 2013
© 2013 thepharmaletter.com